Haley L. Klimaszewski, BS¹, Christoph Weigel, PhD², Selamawit Addissie, MD³, Sarah Schlotter, MPH⁴, Tounkara Fode, PhD^5*, James P. Dugan, MD⁶, Bradley M. Haverkos, MD, MS, MPH⁷, Lynda Villagomez, MD⁸, Mark Lustberg, MD^9*, Pierluigi Porcu, MD¹⁰, Timothy Voorhees, MD, MSCR¹¹, Michael A Caligiuri, MD¹², Christopher C. Oakes, PhD^13,14,15, Ginny Bumgardner, MD, PhD^16* and Robert Baiocchi, MD^2,13

¹College of Medicine, The Ohio State, Columbus, OH
²Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH
³Department of Internal Medicine, John's Hopkins, Baltimore, MD
⁴College of Medicine, The Ohio State University, Columbus, OH
⁵Center for Biostatistics, The Ohio State University, Columbus, OH
⁶Malignant Hematology and Cellular Therapy Department, Novant Health Cancer Institute - Forsyth Medical Center, Winston-Salem, NC
⁷Division of Hematology, University of Colorado School of Medicine, Aurora, CO
⁸Department of Pediatrics, Division of Hematology and Oncology, The Ohio State University and Nationwide Children's Hospital, Columbus, OH
⁹Division of Infectious Disease, Department of Internal Medicine, Yale School of Medicine, New Haven, CT
¹⁰Division of Hematologic Malignancies and Hematopoietic Stem Cell Transplantation, Department of Medical Oncology, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA
¹¹Department of Hematology, James Comprehensive Cancer Center, The Ohio State University, Columbus, OH
¹²Department of Hematology & Hematopoietic Cell Transplantation, City of Hope National Medical Center, Los Angeles, CA
¹³Comprehensive Cancer Center, The James Cancer Hospital and Solove Research Institute, The Ohio State University, Columbus, OH
¹⁴Department of Biomedical Informatics, The Ohio State University, Columbus, OH
¹⁵Division of Hematology, Department of Internal Medicine, Comprehensive Cancer Center, The Ohio State University, Columbus, OH
¹⁶Comprehensive Transplant Center, Department of Surgery, The Ohio State University College of Medicine, Columbus, OH

Supriya Gupta, MD^1*, Christopher Graham, MD² and Philip A Haddad, MD³

¹LSUHSC-S/Feist-Weiller Cancer Center, Shreveport, LA
²Feist-Weiller Cancer Center, LSUHSC-S, Shreveport, LA
³Feist-Weiller Cancer Center, LSUHSC-S/Overton Brooks VAMC, Shreveport, LA

Jincheng Zhao^1*, Jian Rong^2*, Yue Teng^3*, Man Chen^4*, Bing Chen⁵, Chong Jiang^6*, Jianxin Chen^2* and Jingyan Xu, MD^7*

¹Department of Hematology, China Pharmaceutical University Nanjing Drum Tower Hospital, Nanjing, AL, China
²The Key Laboratory of Broadband Wireless Communication and Sensor Network Technology (Ministry of Education), Nanjing University of Posts and Telecommunications, Nanjing, China
³Department of Nuclear Medicine, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing, China
⁴Department of Hematology, China Pharmaceutical University Nanjing Drum Tower Hospital, Nanjing, China
⁵Department of Hematology, Nanjing Drum Tower Hospital, Affiliated Hospital of Nanjing University Medical School, Nanjing, China
⁶Department of Nuclear Medicine, West China Hospital, Sichuan University, Chengdu, China
⁷Department of Hematology, The Affliated Drum Tower Hospital, Nanjing, China

Magdalena Klanova^1,2*, Samuel Hricko, MD^3*, Michal Masar, MD^4*, David Salek, MD^3*, Prokop Vodicka^5*, Natasa Kopalova^3*, Petra Blahovcova^5*, Katerina Benesova, MD, CSc^4*, Jozef Michalka, MD^3*, Jan Koren, MD^4*, Andrea Janikova, Asoc. prof., PhD, MD^3* and Marek Trneny, Prof., MD, PhD⁵

¹First Dept. of Internal Medicine- Hematology, General University Hospital, Charles University, Prague 2, AL, Czech Republic
²Institute of Pathological Physiology, First Faculty of Medicine, Charles University, Prague, Czech Republic
³Faculty of Medicine Masaryk University and University Hospital Brno, Brno, Czech Republic
⁴First Department of Medicine, First Faculty of Medicine, Charles University and General Hospital, Prague, Czech Republic
⁵First Dept. of Internal Medicine- Hematology, General University Hospital, Charles University, Prague, Czech Republic

Tao Yang^1*, Yang Liang, MD, PhD², Chaoyu Wang^1*, Jun Liu^1*, Yan Wu^3*, Haiyan Min^4*, Yunhong Huang^5*, Guo Wei^6*, Wei Zhang^7*, Min Wang^8*, Xiaoqiong Tang^9*, Zailin Yang^1*, Li Jun, MD^1*, Hui Zhou^10* and Yao Liu, PhD, MD¹

¹Department of Hematology-Oncology, Chongqing University Cancer Hospital, Chongqing, China
²Department of Hematologic Oncology, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, China
³Henan Infectious Disease Hospital, The Sixth People’s Hospital of Zhengzhou, Zhengzhou, China
⁴The Second Affiliated Hospital of Kunming Medical University, Kunming, China
⁵The Affiliated Cancer Hospital of Guizhou Medical University, Guiyang, China
⁶public health clinical center of Chengdu, Chengdu, China
⁷Department of Hematology, Peking Union Medical College Hospital, Beijing, China, Beijing, China
⁸The First Hospital of Changsha, Changsha, China
⁹Department of Hematology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China
¹⁰Hunan Cancer Hospital, Changsha, China

Tommy Li, PhD^1*, Leonid Gibiansky, PhD^2*, Apurvasena Parikh, PhD^3*, Marcel van der Linden^4*, Kinjal Sanghavi, PhD^1*, Matthew Putnins, PhD^1*, Mariana Sacchi, MD^1*, Huaibao Feng, PhD^1*, Tahamtan Ahmadi, MD, PhD^5*, Manish Gupta, PhD^1* and Steven Xu, PhD^1*

¹Genmab, Plainsboro, NJ
²QuantPharm LLC, North Potomac, MD
³AbbVie Inc., South San Francisco, CA
⁴Genmab, Utrecht, Netherlands
⁵Genmab US, Inc., Plainsboro, NJ

Heidi Mocikova^1*, Andrea Janikova, Asoc. prof., PhD, MD^2*, Alice Sykorova^3*, Vit Prochazka, Prof., MD, PhD^4,5*, Jan Pirnos^6*, Juraj Duras^7*, Katerina Kopeckova^8*, Katerina Steinerova, MD, PhD^9*, Robert Pytlik, MD, PhD^10*, Petra Blahovcova^11*, David Salek, MD^2*, Tomas Kozak^12*, Veronika Bachanova, MD, PhD¹³ and David Belada, MD^14*

¹Department of Haematology, University Hospital Kralovske Vinohrady and Third Faculty of Medicine, Charles University, Prague, AE, Czech Republic
²Faculty of Medicine Masaryk University and University Hospital Brno, Brno, Czech Republic
³4th Department of Internal Medicine– Hematology, University Hospital and Faculty of Medicine, Hradec Kralove, CZE
⁴Department of Haemato-Oncology, Faculty of Medicine and Dentistry, Palacky University and University Hospital, Olomouc, Olomouc, Czech Republic
⁵Faculty of Medicine and Dentistry, Palacky University, Olomouc, Czech Republic
⁶Ceske Budejovice Hospital, Ceske Budejovice, Czech Republic
⁷Department of Hemato-Oncology, University Hospital and Faculty of Medicine, Ostrava, CZE
⁸2nd Faculty of Medicine of Charles University and University Hospital In Motol, Prague, CZE
⁹Department of Haemato-Oncology, Faculty of Medicine, Charles University and University Hospital Pilsen, Pilsen, Czech Republic
¹⁰Institute of Hematology and Blood Transfusion, Prague, Czech Republic
¹¹First Department of Medicine, First Faculty of Medicine, Charles University and General Hospital, Prague, Czech Republic
¹²Department of Haematology, University Hospital Kralovske Vinohrady and Third Faculty of Medicine, Charles University, Prague, CZE
¹³Division of Hematology, Oncology, and Transplantation, Department of Medicine, University of Minnesota, Minneapolis, MN
¹⁴4th Department of Internal Medicine - Hematology, University Hospital and Faculty of Medicine, Hradec Kralove, Czech Republic

Guido Ghilardi, MD^1*, Luca Paruzzo, MD^1*, Jakub Svoboda, MD², Elise A. Chong, MD³, Alexander Shestov^4*, Linhui Chen^1*, Ivan J Cohen, PhD^1*, Giulia Gabrielli, MD^5*, Dwivedy S. Nasta, MD^3*, Patrizia Porazzi, PhD^1*, Daniel J. Landsburg, MD³, James Gerson, MD^3*, Jordan Carter, MD^3*, Stefan K. Barta, MD³, Rebecca Yelton, BA^3*, Raymone Pajarillo, MS^1*, Griffin W White^3*, Hatcher Ballard, BS^1*, Elizabeth Weber^6*, Ellen B. Napier, CRNP^7*, Emeline R. Chong^3*, Joseph A Fraietta, PhD^4*, Alfred L. Garfall, MD, MTR², David L. Porter, MD³, Michael C. Milone, MD, PhD^4*, Roderick O'Connor, PhD^4*, Stephen J. Schuster, MD⁷ and Marco Ruella, MD¹

¹Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA
²Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA
³Abramson Cancer Center, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA
⁴Center for Cellular Immunotherapies, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA
⁵Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA
⁶Cell Therapy and Transplant, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA
⁷Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA

Corrado Benevolo Savelli, MD^1,2*, Mattia Novo, MD^2*, Francesco Vassallo, MD^3*, Andrea Evangelista^4*, Matteo Bisio, MD^1,2*, Luca Legato, MD^1,2*, Veronica Peri, MD^5*, Michele Clerico^6*, Mario Levis, MD, PhD^7*, Sara Bartoncini, MD^7*, Chiara Cavallin, MD^7*, Maura Nicolosi, MD, PhD^2*, Carola Boccomini, MD^2*, Lorella Orsucci, MD^8*, Federica Cavallo^6*, Benedetto Bruno, MD, PhD⁹, Roberto Freilone, MD^2*, Umberto Ricardi, MD^7* and Barbara Botto^2*

¹University of Turin, Torino, Italy
²Hematology Division, A.O.U Città della Salute e della Scienza di Torino, Torino, Italy
³Hematology Unit, Santa Croce e Carle Hospital, Cuneo, Italy
⁴Unit of Cancer Epidemiology, A.O.U Città della Salute e della Scienza di Torino, Torino, Italy
⁵Division of Hematology, Department of Molecular Biotechnologies and Health Sciences, University of Torino, Torino, Italy
⁶Division of Hematology, Department of Molecular Biotechnology and Health Sciences, University of Torino, A.O.U., Città della Salute e della Scienza di Torino, Torino, Italy
⁷Department of Oncology, University of Torino, Torino, Italy
⁸Hematology Division, A.O.U Città della Salute e della Scienza, Ospedale S. Giovanni Battista Molinette, Torino, Italy
⁹Division of Hematology ,Department of Molecular Biotechologies and Health Sciences, University of Torino,Division of Hematology and Stem cell transplant unit, AOU Città della Salute e della Scienza, Torino, Italy

Prokop Vodicka^1,2*, Andrea Janikova, Asoc. prof., PhD, MD^2,3*, David Belada, MD^2,4*, Heidi Mocikova, MD, PhD^2,5*, Vit Prochazka, Prof., MD, PhD^2,6*, Juraj Duras, MD, PhD^2,7*, Katerina Steinerova, MD, PhD^2,8*, Vit Campr, MD^2,9*, Katerina Benesova, MD, CSc^1*, Samuel Hricko, MD^10*, Alice Sykorova, MD, PhD^11*, Petra Blahovcova^1,2*, Radek Jaksa, MD, PhD^12*, Magdalena Klanova, MD, PhD^1* and Marek Trněný, MD^1,2

¹First Department of Medicine, First Faculty of Medicine, Charles University and General Hospital, Prague, Czech Republic
²Czech Lymphoma Study Group, Prague, Czech Republic
³Department of Hematology and Oncology, Faculty of Medicine Masaryk University and University Hospital Brno, Brno, Czech Republic
⁴4th Department of Internal Medicine - Hematology, University Hospital and Faculty of Medicine, Hradec Kralove, Czech Republic
⁵Department of Hematology, University Hospital Kralovske Vinohrady and Third Faculty of Medicine, Charles University, Prague, Czech Republic
⁶Department of Haemato-Oncology, Faculty of Medicine and Dentistry, Palacky University and University Hospital, Olomouc, Olomouc, Czech Republic
⁷Department of Hematology, Medical Faculty of the Ostrava University and University Hospital, Ostrava, Ostrava, Czech Republic
⁸Department of Haemato-Oncology, Faculty of Medicine, Charles University and University Hospital Pilsen, Pilsen, Czech Republic
⁹Department of Pathology and Molecular Medicine, Second Faculty of Medicine, Charles University and Motol University Hospital, Prague, Czech Republic
¹⁰Department of Hematology and Oncology, Faculty of Medicine, Masaryk University and University Hospital, Brno, Brno, Czech Republic
¹¹4th Department of Internal Medicine – Hematology, Faculty of Medicine, Charles University and University Hospital Hradec Kralove, Hradec Kralove, Hradec Kralove, Czech Republic
¹²Department of Pathology, First faculty of Medicine, Charles University and General University Hospital, Prague, Prague, Czech Republic

Fateeha Furqan, MBBS¹, Katelin Baird, BS^2*, Merve Kacar^3*, Annika S Surapaneni^4*, Ulrich Kemmo Tsafack^5*, Aniko Szabo, PhD^6*, Jakub Svoboda, MD⁷, Brian T. Hill, MD⁸, Jason T. Romancik, MD² and Nirav N. Shah, MD¹

¹Division of Hematology/Oncology, Medical College of Wisconsin, Milwaukee, WI
²Department of Hematology and Medical Oncology, Winship Cancer Institute at Emory University, Atlanta, GA
³Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH
⁴Lymphoma Program, Abramson Cancer Center, The University of Pennsylvania, Philadelphia, PA
⁵Medical College of Wisconsin, Milwaukee
⁶Medical College of Wisconsin, Milwaukee, WI
⁷Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA
⁸Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic Foundation, Cleveland, OH

Patrick Connor Johnson, MD¹, Netana Markovitz, MD^2*, Richard Newcomb, MD^3*, Daniel Yang^4*, Julia Rice^4*, Bridget Coffey^5*, Oreofe O. Odejide, MD, MPH⁶ and Areej El-Jawahri, MD⁷

¹Cancer Center, Massachusetts General Hospital, Boston, MA
²Beth Israel Deaconess Medical Center, Boston
³Massachusetts General Hospital, Winthrop, MA
⁴Massachusetts General Hospital, Boston, MA
⁵Massachusetts General Hospital, Boston
⁶Dana-Farber Cancer Institute, Boston, MA
⁷Massachusetts General Hospital, Allston, MA

Yige Shen^1*, Shu Cheng^2*, Pengpeng Xu^3*, Li Wang, MD^2* and Weili Zhao²

¹National Research Center for Translational Medicine at Shanghai, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China
²Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Rui Jin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China
³Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Rui Jin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, CHN

Shuang Huang^1*, Xiaomei Yang^2*, Yanlong Duan^1*, Ling Jin^1*, Fu Li^2*, Mincui Zheng^3*, Pan Wu^3*, Ying Liu^4*, Bo Hu^4*, Yunpeng Dai^5*, Guotao Guan^5*, Ansheng Liu^6*, Shuang Qin^6*, Lirong Sun^7*, Jian Jiang^7*, Wei Liu, MD^8*, Jianwen Zhou^8*, Jian Wang^9*, Lijun Qu^9*, Leping Zhang^10*, Yueping Jia^10*, Xiaojun Yuan^11*, Yushuang Dong^11*, Baoxi Zhang^12*, Lian Jiang^13*, ZhuJun Wang^14*, XiGe Wang^15*, Shuquan Zhuang^16*, Chunju Zhou^17*, Zifen Gao^18*, Jing Yang^1* and Yonghong Zhang^4*

¹Department of Pediatric Oncology, National Center for Children's Health, Beijing Children's Hospital, Capital Medical University, Beijing, China
²Department of Pediatric Hematology/Oncology, Shandong University Affiliated Hospital (Jinan Children's Hospital), Jinan, China
³Department of Hematology, Hunan Children's Hospital, Changsha, China
⁴Department of Pediatric Lymphoma, Beijing Gobroad Boren Hospital, Beijing, China
⁵Department of Pediatrics Hematology and Endocrinology, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, China
⁶Department of Hematologic Oncology, Xi'an Children's Hospital, Xi'an, China
⁷Department of Pediatric Hematology and Oncology, Affiliated Hospital of Qingdao University, Qingdao, China
⁸Department of Hematology & Oncology, Zhengzhou Children's Hospital, Zhengzhou, China
⁹Department of Hematology and Oncology, Anhui Provincial Children’s Hospital, Hefei, China
¹⁰Department of Pediatrics, Peking University People's Hospital, Beijing, China
¹¹Department of Pediatric Hematology and Oncology, Xinhua Hospital Affiliated to Shanghai Jiaotong University School of Medicine, Shanghai, China
¹²Department of Pediatrics, The Second Hospital of Hebei Medical University, Shijiazhuang, China
¹³Department of Pediatrics, The fourth Hospital of Hebei Medical University, Shijiazhuang, China
¹⁴Department of Pediatrics, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China
¹⁵Department of Pediatrics, the Third Affiliated Hospital of Zhengzhou University, Zhengzhou, China
¹⁶Department of Pediatric,Quanzhou First Hospital Affiliated to Fujian Medical University, Quanzhou, China
¹⁷Department of Pathology, National Center for Children's Health, Beijing Children's Hospital, Capital Medical University, Beijing, China
¹⁸Department of Pathology, Peking University Third Hospital, Beijing, China

Ana Jimenez Ubieto^1*, Rodrigo Gil Manso^2*, Daniel Gil Alós^2*, María Poza Santaella^2*, Tycho Baumann^2*, Antonia Rodriguez Izquierdo^2*, Marina Quesada Sánchez^2*, Pilar Martinez Sanchez, M.D.^3*, Carlos Grande, MD, PhD^4*, Renata Garcia Gigorro^5*, Maria Calbacho^2*, Santiago Barrio, PhD^6* and Joaquin Martinez Lopez, PhD, MD^2*

¹Hospital Universitario 12 de Octubre, MADRID, MADRID, Spain
²Hospital Universitario 12 de Octubre, Madrid, Spain
³Hematology Department, Hospital Universitario 12 de Octubre, Madrid, Spain
⁴Clínica Universidad de Navarra, Madrid, Spain
⁵Medicina Intensiva, Hospital Universitario Infanta Leonor, Madrid, Spain
⁶Department of Hematology, Hospital Universitario 12 de Octubre, Spanish National Cancer Research Center (CNIO), Complutense University Madrid, Madrid, Spain

Gustav Cederquist, MD, PhD^1*, Javin Schefflein, MD^2*, Sean M. Devlin, PhD^3*, Harper Hubbeling, MD¹, Kathryn Tringale, MD, MAS^1*, Gunjan L. Shah⁴, Ana Alarcon Tomas, MD^4*, Roni Shouval, MD, PhD⁵, Carla Hajj, MD^1*, Beatrice Fregonese, MPH^1*, Parastoo B. Dahi, MD^5*, Richard J. Lin, MD, PhD⁵, Maria Lia Palomba, MD⁶, Miguel-Angel Perales, MD⁷, Gilles Salles, MD, PhD⁶, Lorenzo Falchi, MD⁶, Christian Grommes, MD^8*, Michael Scordo⁵, Joachim Yahalom, MD¹ and Brandon S. Imber, MD, MA¹

¹Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY
²Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY
³Department of Biostatistics and Epidemiology, Memorial Sloan Kettering Cancer Center, New York, NY
⁴Memorial Sloan Kettering Cancer Center, New York, NY
⁵Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
⁶Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York
⁷Adult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
⁸Department of Neurology, Memorial Sloan Kettering Cancer, New York, NY

Thomas Curley, MD¹, Wei Wei^2*, Christine Cordova, MD^1*, David Peereboom, MD^1*, Mina Lobbous, MD, MSPH^1* and Allison Winter, MD¹

¹Cleveland Clinic Taussig Cancer Institute, Cleveland, OH
²Quantitative Health Sciences, Lerner Research Institute, Cleveland Clinic, Cleveland, OH

Daisuke Ikeda^1*, Mitsuaki Oura^2*, Atsushi Uehara^2*, Rikako Tabata^2*, Kentaro Narita^2*, Masami Takeuchi^2*, Youichi Machida^3* and Kosei Matsue²

¹Division of Hematology/Oncology, Kameda Medical Center, Kamogawa-Shi, CHI, Japan
²Division of Hematology/Oncology, Kameda Medical Center, Chiba, Japan
³Department of Radiology, Kameda Medical Center, Chiba, JPN

Jing Chen, DO^1*, Zhen Cai, PhD, MD^1* and Yi Zhao^2*

¹Bone Marrow Transplantation Center, Department of Hematology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
²Bone Marrow Transplantation Center, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China

Shannon McGue, MD¹, Andrea Sitlinger, MD^2*, Sophia Chang^3*, Annie Wang^3*, Samantha Thomas, MS^2* and Jie Wang, MD, MS⁴

¹Duke Internal Medicine, Durham, NC
²Duke Cancer Center, Durham, NC
³Duke Medical School, Durham, NC
⁴Duke University, Hillsborough, NC

Julio C. Chavez, MD^1*, Loretta J. Nastoupil, MD², Franck Morschhauser³, Guillaume Cartron, MD, Ph-D^4*, Judit Mészáros Joergensen, MD, PhD^5*, Emmanuel Bachy, MD, PhD^6*, Pierre Bories, MD, PhD^7*, Victoria Campbell, MD, PhD^8*, Bijou Fontanet^9*, Poliana P. Patah^10*, Bérengère de Moucheron^11*, Soraya Carrancio, PhD^12*, Xirong Zheng^13*, Chaoqun Mei^14*, Michael Pourdehnad, MD¹⁰ and Jean-Marie Michot, MD^15*

¹Department of Malignant Hematology, University of South Florida/Moffitt Cancer Center, Tampa, FL
²MD Anderson Cancer Center, Houston, TX
³University of Lille, Centre Hospitalier Universitaire de Lille, Lille, AL, France
⁴Centre Hospitalier Universitaire de Montpellier, Montpellier, France
⁵Department of Hematology, Aarhus University Hospital, Aarhus, Denmark
⁶Department of Hematology, Hospices Civils de Lyon, Lyon, France
⁷Early Phase Unit, University Cancer Institute Toulouse Oncopole, Toulouse, France
⁸Department of Hematology, Western General Hospital, Edinburgh, United Kingdom
⁹Institut Bergonié, Bordeaux, France
¹⁰Early Clinical Development, Hematology/Oncology and Cell Therapy, Bristol Myers Squibb, Princeton, NJ
¹¹Center for Innovation and Translational Research Europe (CITRE), Bristol Myers Squibb, Seville, Spain
¹²Oncogenesis (ONC) Thematic Research Center (TRC), Bristol Myers Squibb, San Diego, CA
¹³Clinical Pharmacology, Pharmacometrics, Disposition & Bioanalysis, Bristol Myers Squibb, Princeton, NJ
¹⁴Global Biometrics and Data Sciences, Bristol Myers Squibb, Berkeley Heights, NJ
¹⁵Département d'Innovation Thérapeutique et d'Essais Précoces (DITEP), Gustave Roussy Institute of Cancer, Villejuif, France

Christian Grommes, MD^1*, Han Tun, MD², Allison C. Rosenthal, DO³, Matthew A. Lunning, DO, FACP^4*, Radhakrishnan Ramchandren, MD⁵, Lucia Regales, PhD^6*, Wanying Zhao, PhD^6*, Maureen Lane, PhD^6*, Catherine Wang, MD^6*, Reinhard von Roemeling, MD⁶, Iris Isufi⁷, Lori A. Leslie, MD⁸ and Grzegorz S. Nowakowski, MD⁹

¹Department of Neurology, Memorial Sloan Kettering Cancer, New York, NY
²Division of Hematology and Medical Oncology, Mayo Clinic, Jacksonville, FL
³Division of Hematology and Medical Oncology, Mayo Clinic, Phoenix, AZ
⁴University of Nebraska Medical Center, Omaha, NE
⁵University of Tennessee Medical Center, Knoxville, TN
⁶Curis Inc., Lexington, MA
⁷Department of Internal Medicine, Yale School of Medicine, Yale University, New Haven, CT
⁸Lymphoma Division, John Theurer Cancer Center, Hackensack Meridian School of Medicine, Hackensack, NJ
⁹Division of Hematology, Mayo Clinic, Rochester, MN

Daisuke Ikeda^1*, Tatsuya Isezaki^2*, Satoshi Yuyama^2*, Kentaro Narita^3*, Mitsuaki Oura^3*, Atsushi Uehara^3*, Rikako Tabata^3*, Masami Takeuchi^3* and Kosei Matsue³

¹Division of Hematology/Oncology, Kameda Medical Center, Kamogawa-Shi, CHI, Japan
²Department of pharmacology, Kameda Medical Center, Chiba, Japan
³Division of Hematology/Oncology, Kameda Medical Center, Chiba, Japan

Ayumi Fujimoto, MD¹, Wataru Munakata^2*, Gakuto Ogawa^3*, Tomotaka Suzuki^4*, Kazuyuki Shimada⁵, Tsutomu Kobayashi^6*, Ken Ohmachi, MD^7*, Tomohiro Kinoshita⁸, Kiyoshi Ando^9*, Dai Maruyama¹⁰ and Hirokazu Nagai, MD, PhD¹¹

¹Department of Hematology and Oncology, Shimane University, School of Medicine, Koto-Ku, TKY, Japan
²Department of Hematology, National Cancer Center Hospital, Tokyo, Japan
³JCOG Data Center, National Cancer Center Hospital, Tokyo, Japan
⁴Department of Hematology and Oncology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan
⁵Department of Hematology and Oncology, Nagoya University Graduate School of Medicine, Nagoya, Japan
⁶Department of Hematology, Japanese Red Cross Kyoto Daiichi Hospital, Kyoto, Japan
⁷Department of Hematology and Oncology, Tokai University School of Medicine, Isehara, KAN, Japan
⁸Department of Hematology and Cell Therapy, Aichi Cancer Center Hospital, Nagoya, Japan
⁹Department of Hematology and Oncology, Tokai University School of Medicine, Isehara, Japan
¹⁰Department of Hematology Oncology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan
¹¹Department of Hematology and Oncology Research, National Hospital Organization, Nagoya Medical Center, Nagoya, Japan

Philip A Haddad, MD¹, Frankie Powell Jr., MD², Ankita Gupta, MD^3* and Christopher Graham, MD⁴

¹Feist-Weiller Cancer Center, LSUHSC-S/Overton Brooks VAMC, Shreveport, LA
²LSUHSC-S/Feist-Weiller Cancer Center, Shreveport, LA
³LSUHSC-S/Overton Brooks VAMC, Shreveport
⁴Feist-Weiller Cancer Center, LSUHSC-S, Shreveport, LA

Emil Ramsø Kyvsgaard^1,2,3*, Anna Caroline Hasselbalch Riley, MD^1,2*, Michael Roost Clausen, MD, PhD^4*, Mads Harsløf^1*, Line Dam Heftdal, MD^5*, Carsten Utoft Niemann, MD, PhD^6,7*, Kirsten Grønbæk, MD, DMSc^1,8,9, Martin Hutchings, MD PhD^1,2* and Simon Husby, MD, PhD^1,3*

¹Department of Hematology, Rigshospitalet, Copenhagen, Denmark
²Phase 1 Unit, Rigshospitalet, Copenhagen, Denmark
³Grønbæk Group, Biotech Research and Innovation Centre, BRIC, University of Copenhagen, Copenhagen, Denmark
⁴Department of Hematology, Vejle Hospital, Vejle, Denmark
⁵Viro-immunology Research Unit, Department of Infectious Diseases, Copenhagen, Copenhagen, Denmark
⁶Department of Hematology, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark
⁷Department of Clinical Medicine, Faculty of Health Science, University of Copenhagen, Copenhagen, Denmark
⁸Biotech Research and Innovation Centre, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
⁹Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark

Amneet K Bajwa, MD, MBA^1*, Qiuhong Zhao, MS^1*, Marcus Johannes Geer, MD², Agrima Mian, MD, MBBS³, Chenyu Lin, MD⁴, David Frame, PharmD^2*, James Westholder, PharmD^5*, Justin Tossey, PharmD^1*, Monalisa Ghosh, MD², Ahmed Galal, MD⁴, Nausheen Ahmed, MD⁶, Joseph E. Maakaron, MD⁵, Nathan Denlinger, MS, DO¹, Marcos de Lima, MD^1*, Narendranath Epperla, MD, MS¹, Paolo F. Caimi, MD³ and Timothy Voorhees, MD, MSCR¹

¹James Comprehensive Cancer Center, The Ohio State University, Columbus, OH
²Rogel Cancer Center, University of Michigan, Ann Arbor, MI
³Taussig Cancer Institute, Cleveland Clinic Foundation, Cleveland, OH
⁴Duke University School of Medicine, Durham, NC
⁵Masonic Cancer Center, University of Minnesota, Minneapolis, MN
⁶Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Westwood, KS

Luca Nassi, MD^1*, Giovanni Martino, MD^2*, Barbara Botto^3*, Marco Paulli, MD^4*, Riccardo Bruna, MD^5*, Marianna Palazzo, MD^6*, Alice Parisi, MD^7*, Luigi Petrucci, MD^8*, Alberto Fabbri, MD^9*, Monica Balzarotti, MD^10*, Ombretta Annibali, MD, PhD^11*, Simone Ragaini, MD^12*, Alessandro Re, MD^13*, Guido Gini, MD¹⁴, Benedetta Sordi, MD^6*, Antonio Cuneo, MD^15*, Renato Fanin, MD^16*, Claudio Agostinelli, MD, PhD^17*, Sabino Ciavarella, MD, PhD^18* and Elena Sabattini, MD^17*

¹Hematology, Careggi Hospital and University of Florence, Florence, ITA
²Institute of Hematology and Center for Hemato-Oncology Research, University and Hospital of Perugia, Perugia, Italy
³SC Ematologia, AOU Città della Salute e della Scienza, Torino, Italy
⁴Pathology, IRCCS Fondazione Policlinico San Matteo and University of Pavia, Pavia, PV, ITA
⁵Division of Hematology, Department of Translational Medicine, University of Eastern Piedmont and AOU Maggiore della Carità, Novara, ITA
⁶Hematology Department, Department of Experimental and Clinical Medicine, University of Florence, Florence, ITA
⁷Pathology, Azienda Ospedaliera Universitaria Integrata di Verona, Verona, Italy
⁸Department of Translational and Precision Medicine, 'Sapienza' University of Rome, Roma, ITA
⁹Hematology, Azienda Ospedaliera Universitaria Senese and University of Siena, Siena, ITA
¹⁰Hematology, IRCCS Humanitas Research Hospital, Rozzano, Milano, ITA
¹¹Hematology and Stem Cell Transplantation Unit, Fondazione Policlinico Universitario Campus Bio medico, Rome, Italy
¹²SCDU Ematologia Universitaria, AOU Città della Salute e della Scienza di Torino, Torino, Italy
¹³UC Hematology, ASST Spedali Civili di Brescia, Brescia BS, Italy
¹⁴Hematology Unit, AOU delle Marche-Università Politecnica delle Marche, Ancona, Italy
¹⁵Division of Hematology, University of Ferrara, Ferrara, Ferrara, Italy
¹⁶Hematology, Azienda Sanitaria Universitaria Integrata di Udine, Udine, Italy
¹⁷Haematopathology Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, ITA
¹⁸Hematology, IRCCS Istituto Tumori “Giovanni Paolo II”, Bari, ITA

Elzbieta Iskierka-Jazdzewska^1*, Won Seog Kim, MD^2*, Seok-Goo Cho^3*, Tae Min Kim, MD, PhD^4*, Isidro Jarque^5*, Tadeusz Robak^6*, Michelle Poon^7*, H. Miles Prince^8*, Sung Yong Oh, MD^9*, Francesca Lim^10*, Cecilia Carpio^11*, Tran-Der Tan¹², Sabarish Ayyappan^13*, Antonio Gutiérrez^14*, Huilai Zhang^15*, Junning Cao^16,17, Mingzhi Zhang^18*, Benoit Tessoulin^19*, Jingjin Li^20*, Cristina Ivanescu^21*, Matthew Reaney^22*, Aafia Chaudhry²⁰, Hesham Mohamed²⁰, Srikanth Ambati^20*, James Harnett^20*, Lei Chi^20* and Jan Walewski^23*

¹Copernicus Memorial Hospital, Medical University of Łódź, Lodz, Poland
²Samsung Medical Center, Center for Hematologic Malignancy, Seoul, Korea, Republic of (South)
³Seoul St. Mary's Hospital, The Catholic University of Korea, Seoul, Korea, Republic of (South)
⁴Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea, Republic of (South)
⁵Hospital Universitario La Fe, Valencia, Spain
⁶Medical University of Lodz, Lodz, Poland
⁷Department of Haematology-Oncology, National University Cancer Institute, Singapore, Singapore
⁸Epworth Healthcare and University of Melbourne, Melbourne, VIC, Australia
⁹Dong-A University Hospital, Busan, Korea, Republic of (South)
¹⁰Singapore General Hospital, Singapore, Singapore
¹¹Vall D' Hebron Hospital, Barcelona, Spain
¹²Koo Foundation Sun Yat Sen Cancer Center, Taipei City, Taiwan
¹³University of Iowa Hospital and Clinics, Iowa City, IA
¹⁴Hospital Universitari Son Espases, IdISBa Palma, Palma de Mallorca, Spain
¹⁵Tianjin Medical University Cancer Institute and Hospital, Tianjin, China
¹⁶Department of Lymphoma, Fudan University Shanghai Cancer Center, Shanghai, China
¹⁷Fudan University Shanghai Cancer Center, Shanghai, China
¹⁸The First Affiliated Hospital of Zhengzhou University and Lymphoma Diagnosis and Treatment Center of Henan Province, Zhengzhou, Henan, China
¹⁹Nantes University School of Medicine & University Hospital, Nantes, France
²⁰Regeneron Pharmaceuticals, Inc., Tarrytown, NY
²¹IQVIA, Amsterdam, Netherlands
²²IQVIA Inc., Durham, NC
²³Narodowy Instytut Onkologii im. Marii Skłodowskiej-Curie Państwowy Instytut Badawczy, Warszawa, Poland

Valentin Daguerre^1*, Elisabeth Daguenet, PhD^1*, Nicolas Jacquet-Francillon^2*, Ludovic Fouillet, MD^1*, Ugo Thévenet^1*, Maxime Bonjour^2*, Herve Ghesquieres, MD, PhD^3*, Imran Ahmad, MD⁴ and Jerome Cornillon, MD^1*

¹Hématologie, CHU de Saint-Etienne, Saint-Etienne, France
²CHU de Lyon, Lyon, France
³Hematology Department, Hopital Lyon Sud - HCL, Lyon, France
⁴Hematology-Oncology and Cell Therapy University Institute, Maisonneuve-Rosemont Hospital, University of Montreal, Montreal, QC, CAN

Xi Chen^1*, Yingying Chen^2*, Tao Lei^1*, Haifeng Yu^1*, Cong Li, MD^1*, Yongwei Hong^2* and Haiyan Yang¹

¹Department of Lymphatic Oncology, Zhejiang Cancer Hospital, Hangzhou, China
²Ningbo Yinzhou NO.2 Hospital, Ningbo, China

Hui SHI^1*, Kai HU^1* and Xiaoyan Ke^2,3*

¹Department of Lymphoma and Myeloma Research Center, Beijing Gobroad Boren Hospital, Beijing, China
²Peking University Third Hospital, Beijing, China
³Department of Lymphoma and Myeloma Research Center, Beijing Gobroad Boren Hospital, Beijing, China

Daniel Rosas, MD^1,2, Esteban Toro Velez, MD³, Carolina Velez-Mejia, MD⁴, Qianqian Liu, PhD^5*, Joel Michalek, PhD^5* and Adolfo Enrique Diaz Duque, MD⁶

¹Memorial Healthcare System, pembroke pines, FL
²MD Anderson, University of Texas Health San Antonio, San Antonio
³University of Texas Health-San Antonio, San Antonio, TX
⁴University of Texas San Antonio, San Antonio, TX
⁵Department of Population Health Sciences, University of Texas Health-San Antonio, San Antonio, TX
⁶MD Anderson, University of Texas San Antonio, San Antonio, TX

Rizine R Mzikamanda II, MBBS^1,2*, Loviisa Mulanje, MBBS^3*, Apatsa Matatiyo, MBBS^4*, Zoe Mwale, MBBS^5,6*, Gugulethu Mapurisa, MBBS, MMED^4*, Ruth Namazzi, MD^7*, Nader Kim El-Mallawany, MD⁸, Casey Lee McAtee, MD, MPH^8,9, Katherine Douglas Westmoreland, MD^10*, Carl E Allen, MD⁸ and Nmazuo Ozuah, MBBS^8,9

¹Baylor College of Medicine Children’s Foundation – Malawi, Lilongwe, AL, Malawi
²Global Hematology Oncology Pediatric Excellence- Malawi, Texas Childrens Hospital, Lilongwe, Malawi
³Department Epidemiological Methods and Etiological Research, Leibniz Institute for Prevention Research and Epidemiology - BIPS, Bremen, Germany
⁴UNC Project Malawi, Lilongwe, Malawi
⁵Baylor College Of Medicine Children's Foundation, Malawi, Lilongwe, Malawi
⁶Kamuzu Central Hospital, Lilongwe, Malawi
⁷Department of Paediatrics, Makerere University, Kampala, Uganda
⁸Baylor College of Medicine, Houston, TX
⁹Baylor College of Medicine Children’s Foundation – Malawi, Lilongwe, Malawi
¹⁰UNC Project Malawi, Chapel Hill, NC

Prokop Vodicka^1*, Michal Masar, MD^1*, Magdalena Klanova, MD, PhD^1*, Katerina Benesova, MD, CSc^1*, Jan Koren, MD^1*, Pavel Klener, Prof., MD, PhD^1*, Petra Blahovcova^1,2*, Jitka Dlouha^1,2*, Sarka Hrabetova^1* and Marek Trněný, MD^1,2

¹First Department of Medicine, First Faculty of Medicine, Charles University and General Hospital, Prague, Czech Republic
²Czech Lymphoma Study Group, Prague, Czech Republic

Almudena Cabero Martínez^1,2*, Luis Gonzaga Diaz Gonzalez^2*, Carlos Montes^2*, María Cortés-Rodríguez^2*, Norma C. Gutierrez^3*, Monica Baile Gonzalez^4*, Ana García Bacelar^4*, Miriam Lopez Parra^1*, Jose Cristobal Cañadas^4*, Juan Gabriel Villanueva^4*, Francisco Javier Diaz Galvez^5*, María Peñarrubia-Ponce^6*, Silvia Maria Fernandez Ferrero^7*, Jose Antonio Queizan Hernandez, MD^8*, Miguel Cabezudo^9*, Erik De Cabo López^10*, Teresa Villaescusa^11*, Pilar Tamayo^4*, Ramon Garcia-Sanz⁴ and Alejandro Martin García-Sancho^4*

¹Hospital Universitario de Salamanca, Instituto de Investigacion Biomedica de Salamanca (IBSAL), Centro de Investigación del Cancer (IBMCC-USAL, CSIC), Salamanca, Spain
²Hospital de Salamanca, Salamanca, Spain
³Hospital Universitario De Salamanca, Salamanca, ESP
⁴Hospital Universitario de Salamanca, Salamanca, Spain
⁵Hospital Universitario de Burgos, BURGOS, ESP
⁶Hospital ClíNico Universitario De Valladolid, Valladolid, ESP
⁷Hospital de León, Leon, ESP
⁸Hematology Department - Hospital General de Segovia, Segovia, Spain
⁹Hospital de Ávila, Ávila, Spain
¹⁰Hospital del Bierzo, Ponferrada, Spain
¹¹Hospital de Zamora, Zamora, ESP

Matthew J. Maurer, DSc¹, Arushi Khurana, MBBS², Umar Farooq³, Jason T. Romancik, MD⁴, Jonathan W. Friedberg, MD, MMSc⁵, Izidore S. Lossos, MD⁶, Brad S. Kahl, MD⁷, Peter Martin, MD⁸, Dai Chihara, MD, PhD⁹, Andrew L. Feldman, MD¹⁰, Sergei Syrbu, MD, PhD^11*, David L Jaye, MD¹², Elliot Cahn^13*, Thomas M. Habermann, MD¹⁴, Brian K. Link, MD^15*, James R. Cerhan, MD, PhD¹⁶, Christopher R. Flowers, MD, MS⁹, Loretta J. Nastoupil, MD¹⁷ and Grzegorz S. Nowakowski, MD¹⁴

¹Division of Clinical Trial and Biostatistics, Mayo Clinic, Rochester, MN
²Mayo Clinic, Rochester, MN
³Division of Hematology, Oncology and Blood & Marrow Transplantation, University of Iowa Hospitals and Clinics, Iowa City, IA
⁴Department of Hematology and Medical Oncology, Winship Cancer Institute at Emory University, Atlanta, GA
⁵Wilmot Cancer Center, University of Rochester, Rochester, NY
⁶Sylvester Comprehensive Cancer Center, Division of Hematology, University of Miami School of Medicine, Miami, FL
⁷Washington University School of Medicine in St. Louis, Saint Louis, MO
⁸Division of Hematology and Medical Oncology, Weill Cornell Medicine, New York, NY
⁹Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
¹⁰Department of Laboratory Medicine and Pathology, Division of Hematopathology, Mayo Clinic, Rochester, MN
¹¹University of Iowa, Iowa City, IA
¹²Department of Pathology and Laboratory Medicine, Emory University, Atlanta, GA
¹³Mayo Clinic, Division of Clinical Trials and Biostatistics, Rochester, MN
¹⁴Division of Hematology, Mayo Clinic, Rochester, MN
¹⁵Division of Hematology, Oncology, and Blood & Marrow Transplantation, University of Iowa Hospitals and Clinics, Iowa City, IA
¹⁶Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN
¹⁷MD Anderson Cancer Center, Houston, TX

Madhan Srinivasan Kumar, MD¹, Veena Gujju, MD^2*, Ji Hwan Park, PhD^3*, Debra Hogue, M.S.^3*, Abdul Rafeh Naqash, MD^4* and Taha Mahdi Salih Al-Juhaishi, MD⁵

¹Internal Medicine, Saint Vincent Hospital, Worcester, MA
²Department of Medicine – Section of Hematology and Medical Oncology, Baylor College of Medicine, Houston, TX
³School of Computer Science, University of Oklahoma, Norman, OK
⁴Hematology and Medical Oncology, TSET Phase 1 Program, University of Oklahoma Health Sciences Center - Stephenson Cancer Center, Oklahoma City, OK
⁵Hematology and Medical Oncology, Stem Cell Transplantation and Cellular Therapy Program, University of Oklahoma Health Sciences Center - Stephenson Cancer Center, Oklahoma City, OK